Agenus | AGEN - Gross Profit On Sales

Stock Price
4.13
Daily Change
-0.04 -0.96%
Monthly
1.72%
Yearly
40.00%
Q2 Forecast
3.76

Agenus reported $34.2M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Agenus USD 34.2M 4.61M Dec/2025
Amgen USD 6.89B 415M Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Celldex Therapeutics USD 121K 609K Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Eli Lilly USD 15.92B 1.33B Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
Incyte USD 1.17B 217.51M Mar/2026
Intrexon USD -297K 167K Jun/2024
J&J USD 17.24B 642M Mar/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Karyopharm Therapeutics USD 32.6M 63.38M Dec/2025
MacroGenics USD 31.11M 30.14M Dec/2025
Merck EUR 2.96B 252M Dec/2025
Merck USD 10.85B 2.57B Dec/2025
Novartis USD 10.07B 184M Mar/2026
Novavax USD 125.04M 76.09M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Sangamo BioSciences -2.39M 1.09M Jun/2024
Veracyte USD 101.16M 814K Mar/2026